Andrew Cheng
Impact in
- Virology top 0.1%
- HIV Research and Treatment
- Infectious Diseases top 0.1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 72
- HIV/AIDS Research and Interventions 14
- Virology 22
- HIV Research and Treatment 22
- Co-authors
- Edwin DeJesus (24 shared papers)Joel E. Gallant (16 shared papers)Anton Pozniak (10 shared papers)Lijie Zhong (11 shared papers)Jeffrey Enejosa (9 shared papers)Brian P. Kearney (12 shared papers)Damian J. McColl (9 shared papers)Kirsten White (16 shared papers)
- Journals
- JAIDS Journal of Acquired Immune Deficiency Syndromes (23 papers)The Lancet HIV (8 papers)HIV Clinical Trials (7 papers)The Lancet (5 papers)The Journal of Clinical Pharmacology (5 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Andrew Cheng
94 papers receiving 7.6k citations
Andrew Cheng's Hit Papers
Peers
Comparison fields: 5 of 103
- Virology 2.5k
- Infectious Diseases 5.6k
- Emergency Medicine 1.4k
- Hepatology 586
- Epidemiology 1.4k
Countries citing papers authored by Andrew Cheng
This map shows the geographic impact of Andrew Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Cheng more than expected).
Fields of papers citing papers by Andrew Cheng
This network shows the impact of papers produced by Andrew Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Cheng. The network helps show where Andrew Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV Hit paper breakdown → | 2006 | 724 |
| 2 | 2012 | 361 | |
| 3 | Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial Hit paper breakdown → | 2017 | 292 |
| 4 | 2012 | 277 | |
| 5 | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial Hit paper breakdown → | 2021 | 271 |
| 6 | 2017 | 268 | |
| 7 | 2006 | 235 | |
| 8 | 2002 | 227 | |
| 9 | 2004 | 203 | |
| 10 | 2008 | 191 | |
| 11 | 2006 | 188 | |
| 12 | Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial Hit paper breakdown → | 2023 | 172 |
| 13 | 2003 | 171 | |
| 14 | 2015 | 160 | |
| 15 | 2004 | 158 | |
| 16 | 2016 | 149 | |
| 17 | 2005 | 148 | |
| 18 | 2018 | 144 | |
| 19 | 2004 | 138 | |
| 20 | 2011 | 137 |
About Andrew Cheng
Andrew Cheng is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Epidemiology and Molecular Biology, having authored 95 papers that have together received 7.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (72 papers), HIV Research and Treatment (22 papers), HIV-related health complications and treatments (15 papers), HIV/AIDS Research and Interventions (14 papers), Liver Disease Diagnosis and Treatment (6 papers), Pharmacological Effects and Toxicity Studies (4 papers), Hepatitis B Virus Studies (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Virology (2.5k citations), Infectious Diseases (5.6k citations), Emergency Medicine (1.4k citations), Hepatology (586 citations) and Epidemiology (1.4k citations). Andrew Cheng has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Edwin DeJesus, Joel E. Gallant, Anton Pozniak, Lijie Zhong, Jeffrey Enejosa, Brian P. Kearney, Damian J. McColl, Kirsten White, Michael D. Miller and José Ramón Arribas. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, The Lancet HIV, HIV Clinical Trials, The Lancet and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.